NCT03421054View on ClinicalTrials.gov

Pilot Trial to Assess the Feasibility of Implementing Objective Parameters in Patients Affected by Knee Osteoarthritis

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 19, 2018

Primary Completion Date

April 15, 2018

Study Completion Date

May 14, 2018

Conditions
Knee Osteoarthritis
Interventions
DIETARY_SUPPLEMENT

patients assuming nutraceutical containing HA

pain reduction of the affected knee in the patients assuming nutraceutical containing HA

Trial Locations (1)

300209

Opera Contract Research Organization S.r.l., Timișoara

All Listed Sponsors
collaborator

Opera CRO, a TIGERMED Group Company

OTHER

lead

River Pharma S.r.l.

OTHER

NCT03421054 - Pilot Trial to Assess the Feasibility of Implementing Objective Parameters in Patients Affected by Knee Osteoarthritis | Biotech Hunter | Biotech Hunter